{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:03:00Z","timestamp":1748059380833,"version":"3.41.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"DOI":"10.7759\/cureus.84661","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:18:05Z","timestamp":1747995485000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Presentation of Small Bowel Neuroendocrine Carcinoma Leading to Acute Obstruction"],"prefix":"10.7759","author":[{"given":"Aravind","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Ramlakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Mecheri","family":"Antony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin IM","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003, 97:934-59. 10.1002\/cncr.11105","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.01.003","article-title":"Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - imaging and staging","volume":"30","author":"Baumann T","year":"2016","unstructured":"Baumann T, Rottenburger C, Nicolas G, Wild D. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - imaging and staging. Best Pract Res Clin Endocrinol Metab. 2016, 30:45-57. 10.1016\/j.beem.2016.01.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0017","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape UF","year":"2008","unstructured":"Pape UF, Berndt U, M\u00fcller-Nordhorn J, et al.. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2008, 15:1083-97. 10.1677\/ERC-08-0017","journal-title":"Endocr Relat Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/srep40609","article-title":"Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers","volume":"7","author":"Freis P","year":"2017","unstructured":"Freis P, Graillot E, Rousset P, Hervieu V, Chardon L, Lombard-Bohas C, Walter T. Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers. Sci Rep. 2017, 7:40609. 10.1038\/srep40609","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.6720","article-title":"Therapeutic options for neuroendocrine tumors: a systematic review and network meta-analysis","volume":"5","author":"Kaderli RM","year":"2019","unstructured":"Kaderli RM, Spanjol M, Koll\u00e1r A, et al.. Therapeutic options for neuroendocrine tumors: a systematic review and network meta-analysis. JAMA Oncol. 2019, 5:480-9. 10.1001\/jamaoncol.2018.6720","journal-title":"JAMA Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1294.001","article-title":"The \"normal\" endocrine cell of the gut: changing concepts and new evidences","volume":"1014","author":"Rindi G","year":"2004","unstructured":"Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E. The \"normal\" endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci. 2004, 1014:1-12. 10.1196\/annals.1294.001","journal-title":"Ann N Y Acad Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59655-1","article-title":"Histological Typing of Endocrine Tumours, 2nd Edition","author":"Solcia E","year":"2012","unstructured":"Solcia E, Kl\u00f6ppel G, Sobin LH. Histological Typing of Endocrine Tumours, 2nd Edition. Springer Science & Business Media, Berlin, Germany; 2012. 10.1007\/978-3-642-59655-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(96)90303-2","article-title":"Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables","volume":"27","author":"Pelosi G","year":"1996","unstructured":"Pelosi G, Bresaola E, Bogina G, et al.. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol. 1996, 27:1124-34. 10.1016\/s0046-8177(96)90303-2","journal-title":"Hum Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000085237","article-title":"Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)","volume":"80","author":"Pl\u00f6ckinger U","year":"2004","unstructured":"Pl\u00f6ckinger U, Rindi G, Arnold R, et al.. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology. 2004, 80:394-424. 10.1159\/000085237","journal-title":"Neuroendocrinology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1126\/science.6635661","article-title":"Specific endocrine tissue marker defined by a monoclonal antibody","volume":"222","author":"Lloyd RV","year":"1983","unstructured":"Lloyd RV, Wilson BS. Specific endocrine tissue marker defined by a monoclonal antibody. Science. 1983, 222:628-30. 10.1126\/science.6635661","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i14.1865","article-title":"Colorectal neuroendocrine carcinoma: a case report and review of the literature","volume":"7","author":"Yoshida T","year":"2019","unstructured":"Yoshida T, Kamimura K, Hosaka K, et al.. Colorectal neuroendocrine carcinoma: a case report and review of the literature. World J Clin Cases. 2019, 7:1865-75. 10.12998\/wjcc.v7.i14.1865","journal-title":"World J Clin Cases"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363438-atypical-presentation-of-small-bowel-neuroendocrine-carcinoma-leading-to-acute-obstruction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:18:05Z","timestamp":1747995485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363438-atypical-presentation-of-small-bowel-neuroendocrine-carcinoma-leading-to-acute-obstruction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.84661","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}